# Boehringer Ingelheim Pharmaceuticals, Inc. – FDA Inspection, Sep 1, 2010

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/c891602c-1766-4678-a6ef-20deee5b5b63
Source feed: FDA_Inspections

> FDA inspection 678092 of Boehringer Ingelheim Pharmaceuticals, Inc., September 01, 2010. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. 19 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 678092
- Company Name: Boehringer Ingelheim Pharmaceuticals, Inc.
- Inspection Date: 2010-09-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1334848 - 2026-08-25
- [FDA Inspection 1281125 - 2025-09-11](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/9c62d459-d5fc-4614-8d41-987968509962)
- FDA Inspection 1235545 - 2024-05-02
- FDA Inspection 1219707 - 2023-09-22
- [FDA Inspection 1112627 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/3cec078a-63a0-4054-aba3-a7b39a8fad4e)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c